最新ニュース Equinor (NYSE:EQNR) 株価情報

Equinor

Equinor is a Norway-based integrated oil and gas company. It has been publicly listed since 2001, but the government retains a 67% stake. Operating primarily on the Norwegian Continental Shelf, the firm produced 2.1 million barrels of oil equivalent per day in 2023 (53% liquids) and ended 2023 with 5.2 billion barrels of proven reserves (49% liquids). Operations also include offshore wind, solar, oil refineries and natural gas processing, marketing, and trading.

Equinor ASA

Fox Factory Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOXF#NASDAQ">FOXF</a>) affirms FY2025 Adj EPS guidance from $1.60-$2.60 to $1.60-$2.60 vs $1.90 analyst estimate. Affirms FY2025 sales outlook from $1.39 billion-$1.49 billion to $1.39 billion-$1.49 billion vs $1.42 billion estimate.

News

Guidance

FOXF

Correction: Fox Factory Holding Affirms FY2025 Adj EPS Guidance of $1.60-$2.60 vs $1.90 Est; Affirms FY2025 Sales Guidance of $1.39B-$1.49B vs $1.42B Est

Twin Vee PowerCats Co. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VEEE#NASDAQ">VEEE</a>), ("Twin Vee" or the "Company"), a manufacturer, distributor, and marketer of power sport boats, today announced the pricing its underwritten public offering of 750,000 shares of its common stock. Each share of common stock is being sold at a public offering price of $4.00 per share. Total gross proceeds from the offering, before deducting the underwriting discount and other offering expenses, are expected to be $3,000,000. The offering is expected to close on May 12, 2025, subject to satisfaction of customary closing conditions.
The Company intends to use the net proceeds from the offering primarily for working capital and general corporate purposes.
ThinkEquity is acting as the sole book-running manager for the offering.

Offerings

VEEE

Twin Vee Powercats Announces Pricing Of $3M Public Offering Of 750K Shares At A Price Of $4/Share

SolarBank Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SUUN#NASDAQ">SUUN</a>) (Cboe CA: SUNN) (FSE: GY2) ("SolarBank" or the "Company")&nbsp;announced today that it has filed a final short form base shelf prospectus (the "Shelf Prospectus") with the securities regulatory authorities in each of the provinces of Canada. The Shelf Prospectus replaces the Company's prior final short form base shelf prospectus dated May 2, 2023 which would have expired in June 2025. A corresponding shelf registration statement on Form F-10 (the "Registration Statement") has been filed with the United States Securities and Exchange Commission but is not yet effective.
The Shelf Prospectus will enable the Company to make offerings of up to C$200 million of common shares, debt securities, warrants, subscription receipts, units and share purchase contracts or a combination thereof of the Company from time to time, separately or together, in amounts, at prices and on terms to be determined based on market conditions at the time of the offering and as set out in an accompanying prospectus supplement, during the 25-month period that the Shelf Prospectus remains valid.

SUUN

SolarBank Corporation Files New C$200 Million Shelf Prospectus In Canada And U.S., Replacing 2023 Version, Pending SEC Approval

Equinix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EQIX#NASDAQ">EQIX</a>) has outperformed the market over the past 15 years by 4.19% on an annualized basis producing an average annual return of 15.46%. Currently, Equinix has a market capitalization of $83.80 billion. 
Buying $100 In EQIX: If an investor had bought $100 of EQIX stock 15 years ago, it would be worth $846.76 today based on a price of $860.99 for EQIX at the time of writing.
<h3>Equinix's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746746112_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

EQIX

Here's How Much $100 Invested In Equinix 15 Years Ago Would Be Worth Today

Waste Connections (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WCN#NYSE">WCN</a>) has outperformed the market over the past 10 years by 9.58% on an annualized basis producing an average annual return of 19.98%. Currently, Waste Connections has a market capitalization of $50.53 billion. 
Buying $1000 In WCN: If an investor had bought $1000 of WCN stock 10 years ago, it would be worth $6,175.58 today based on a price of $195.56 for WCN at the time of writing.
<h3>Waste Connections's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746745218_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today

Genmab (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GMAB#NASDAQ">GMAB</a>) reported quarterly earnings of $0.31 per share which beat the analyst consensus estimate of $0.23 by 34.78 percent. This is a 6.9 percent increase over earnings of $0.29 per share from the same period last year. The company reported quarterly sales of $715.00 million which missed the analyst consensus estimate of $748.58 million by 4.49 percent. This is a 19.08 percent increase over sales of $600.43 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

GMAB

Genmab Q1 EPS $0.31 Beats $0.23 Estimate, Sales $715.00M Miss $748.58M Estimate

CeriBell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBLL#NASDAQ">CBLL</a>) raises FY2025 sales outlook from $81.00 million-$85.00 million to $83.00 million-$87.00 million vs $83.72 million estimate.

CBLL

CeriBell Raises FY2025 Sales Guidance from $81.00M-$85.00M to $83.00M-$87.00M vs $83.72M Est

HCI Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCI#NYSE">HCI</a>) reported quarterly earnings of $5.35 per share which beat the analyst consensus estimate of $4.38 by 22.15 percent. This is a 46.58 percent increase over earnings of $3.65 per share from the same period last year. The company reported quarterly sales of $216.43 million which beat the analyst consensus estimate of $214.89 million by 0.72 percent. This is a 4.75 percent increase over sales of $206.61 million the same period last year.

HCI Group Q1 EPS $5.35 Beats $4.38 Estimate, Sales $216.43M Beat $214.89M Estimate

Inseego (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INSG#NASDAQ">INSG</a>) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.08) by 100 percent. This is a 63.64 percent increase over losses of $(0.44) per share from the same period last year. The company reported quarterly sales of $31.67 million which missed the analyst consensus estimate of $32.06 million by 1.20 percent. This is a 29.63 percent decrease over sales of $45.01 million the same period last year.

INSG

Inseego Q1 EPS $(0.16) Misses $(0.08) Estimate, Sales $31.67M Miss $32.06M Estimate

ZipRecruiter (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIP#NYSE">ZIP</a>) sees Q2 sales of $108.000 million-$114.000 million vs $114.22 million analyst estimate.

ZipRecruiter Sees Q2 Sales $108.000M-$114.000M vs $114.22M Est

AVITA Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCEL#NASDAQ">RCEL</a>) affirms FY2025 sales outlook from $100.00 million-$106.00 million to $100.00 million-$106.00 million vs $102.26 million estimate.

RCEL

AVITA Medical Affirms FY2025 Commercial Revenue Guidance of $100.00M-$106.00M vs $102.26M Est

Mach Natural Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MNR#NYSE">MNR</a>) reported quarterly earnings of $0.31 per share which missed the analyst consensus estimate of $0.63 by 50.79 percent. This is a 29.55 percent decrease over earnings of $0.44 per share from the same period last year. The company reported quarterly sales of $226.77 million which missed the analyst consensus estimate of $254.54 million by 10.91 percent. This is a 5.18 percent decrease over sales of $239.16 million the same period last year.

CORRECTION: Mach Natural Resources Q1 Adj. EPS $0.31 Misses $0.63 Estimate, Sales $226.77M Miss $254.54M Estimate

Varex Imaging (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VREX#NASDAQ">VREX</a>) is looking for Q3 Adj EPS of $(0.05)-$0.10 vs $0.16 analyst estimate. sees sales of $180.000 million-$200.000 million vs $210.00 million analyst estimate.

VREX

Varex Imaging Sees Q3 Adj EPS $(0.05)-$0.10 vs $0.16 Est; Sees Sales $180.000M-$200.000M vs $210.00M Est

Shareholders of UnitedHealth Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) filed a class-action lawsuit on Wednesday accusing the company of misleading investors by concealing the negative business impacts that followed the December 2024 killing of UnitedHealthcare <a href="https://www.benzinga.com/news/legal/25/02/43887520/luigi-mangione-back-in-court-friday-supporters-donate-500k-to-suspected-killer">CEO Brian Thompson.</a>
The Details: The lawsuit alleges UnitedHealth withheld critical information regarding the backlash and regulatory scrutiny that arose after the CEO's death, particularly concerning the company's aggressive claims denial practices.&nbsp;
Read Next: <a href="https://www.benzinga.com/general/travel/25/05/45260938/disneys-new-abu-dhabi-theme-park-will-be-authentically-disney-and-distinctly-emirati-ceo-bob-iger-says?utm_source=articleShare">Disney&#8217;s New Abu Dhabi Theme Park Will Be &#8216;Authentically Disney And Distinctly Emirati,&#8217; CEO Bob Iger Says&nbsp;</a>
According to the plaintiffs, the public outcry and scrutiny forced strategic, more "patient-friendly" changes that would reduce the company's profitability.
UnitedHealth had initially forecasted adjusted earnings per share between $29.50 and $30 for 2025 and reaffirmed this outlook in January 2025, despite mounting public and regulatory pressures.&nbsp;
However, on April 17, 2025, the company revised its 2025 profit forecast downward to a range of $26 to $26.50. UnitedHealth stock plunged 22.4%, wiping out approximately $119 billion in market value in one day.&nbsp;
The shareholders contend UnitedHealth's failure to disclose the shift away from its previously aggressive claim denial strategies and the resulting impact on profitability constituted materially false and misleading statements. 
The lawsuit was filed in federal court in Manhattan and named UnitedHealth executives, including CEO Andrew Witty and CFO John Rex, as defendants. It covers the period from Dec. 3, 2024, to April 16, 2025, and seeks damages for shareholders who purchased UnitedHealth shares during that time.
&#8220;The company denies any allegations of wrongdoing and intends to defend the matter vigorously,&#8221; a UnitedHealthcare spokesperson said in a statement to NBC News.&nbsp;
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/legal/25/05/45226604/president-trump-wants-to-reopen-alcatraz-heres-what-it-would-take?utm_source=articleShare">President Trump Wants To Reopen Alcatraz: Here&#8217;s What It Would Take</a></li>
</ul>
Image: Shutterstock

Health Care

Legal

Management

Insurance

General

UnitedHealth Investors Claim Company Hid Profit Impact Of CEO's Murder

Oracle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) has outperformed the market over the past 20 years by 5.21% on an annualized basis producing an average annual return of 13.37%. Currently, Oracle has a market capitalization of $422.43 billion. 
Buying $1000 In ORCL: If an investor had bought $1000 of ORCL stock 20 years ago, it would be worth $12,170.04 today based on a price of $150.64 for ORCL at the time of writing.
<h3>Oracle's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746744319_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ORCL

Here's How Much $1000 Invested In Oracle 20 Years Ago Would Be Worth Today

Strattec Security (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STRT#NASDAQ">STRT</a>) reported quarterly earnings of $1.50 per share which beat the analyst consensus estimate of $0.95 by 57.89 percent. This is a 305.41 percent increase over earnings of $0.37 per share from the same period last year. The company reported quarterly sales of $144.08 million which beat the analyst consensus estimate of $140.84 million by 2.30 percent. This is a 2.35 percent increase over sales of $140.77 million the same period last year.

STRT

UPDATE: Strattec Security Q3 Adj. EPS $1.50 Beats $0.95 Estimate, Sales $144.08M Beat $140.84M Estimate

LPL Finl Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPLA#NASDAQ">LPLA</a>) reported quarterly earnings of $5.15 per share which beat the analyst consensus estimate of $4.67 by 10.28 percent. This is a 22.33 percent increase over earnings of $4.21 per share from the same period last year. The company reported quarterly sales of $3.67 billion which beat the analyst consensus estimate of $3.27 billion by 12.11 percent. This is a 29.54 percent increase over sales of $2.83 billion the same period last year.

LPLA

CORRECTION: LPL Finl Hldgs Q1 Adj. EPS $5.15 Beats $4.67 Estimate, Sales $3.67B Beat $3.27B Estimate

Affirm Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.03) by 133.33 percent. This is a 102.33 percent increase over losses of $(0.43) per share from the same period last year. The company reported quarterly sales of $783.13 million which beat the analyst consensus estimate of $783.03 million by 0.01 percent. This is a 35.92 percent increase over sales of $576.16 million the same period last year.

AFRM

CORRECTION: Affirm Holdings Q3 EPS $0.01 Beats $(0.03) Estimate, Sales $783.13M Beat $783.03M Estimate

Additionally, the board has authorized a new share repurchase program of up to $1 billion of the company's common shares. This replaces the recently completed $1 billion share repurchase program, which was authorized in September 2021. In the second quarter of 2025, the company executed the remainder of its prior authorization by repurchasing approximately $74 million of common shares. Repurchases under the new program may be made through a variety of methods, including but not limited to open market purchases, unsolicited or solicited privately negotiated transactions, tender offers, block trades, accelerated share repurchase transactions, or pursuant to 10b5-1 trading plans.

Buybacks

Weyerhaeuser Authorizes New $1B Share Repurchase Program

Alcoa Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AA#NYSE">AA</a>, ASX: AAI))) (the "Company" or "Alcoa") announced that its Board of Directors (the "Board") has named Thomas J. Gorman as non-executive Chairmanof the Board, effective today, May 8, 2025, immediately upon the conclusion of the Company's 2025 Annual Meeting of Stockholders. Mr. Gorman has served as an independent director of the Board since May 2021, and succeeds Steven W. Williams in that position, who stepped down from the Board effective today after over eight years of service.

Alcoa Corporation Names Thomas J. Gorman As Board Chairman, Effective today, May 8, 2025

Press Releases

Correction: Equinor ASA: Key information relating to cash dividend for third quarter 2024

Equinor ASA: Announcement of cash dividend per share in NOK for third quarter 2024

Equinor presents 2024 Annual report

Correction: Equinor presents 2024 Annual report

Equinor ASA: proposal on capital reduction from the company's board of directors

Equinor ASA: Notice of annual general meeting 14 May 2025

Equinor first quarter 2025 results

Equinor ASA: Key information relating to cash dividend for first quarter 2025

Equinor to commence second tranche of the 2025 share buy-back programme

Equinor sells the Peregrino field for USD 3.5 billion

EQNR

Chevron

Ecopetrol S.A. American Depositary Shares

Ecopetrol

Occidental Petroleum Corporation Common Stock

Occidental Petroleum

Petroleo Brasileiro S.A.- Petrobras Common Stock

Petrobras Brasileiro

Petroleo Brasileiro S.A.- Petrobras American Depositary Shares

Shell PLC American Depositary Shares (each representing two (2) Ordinary Shares)

Comments

Equinor

ニュース

最新ニュース Equinor (NYSE:EQNR) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル